These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32519936)

  • 1. Occurrence of ESBL-Producing
    Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.
    Timofte D; Maciuca IE; Williams NJ; Wattret A; Schmidt V
    Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.
    Tóth K; Tóth Á; Kamotsay K; Németh V; Szabó D
    Ann Clin Microbiol Antimicrob; 2022 Feb; 21(1):3. PubMed ID: 35144632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.
    Jamborova I; Dolejska M; Vojtech J; Guenther S; Uricariu R; Drozdowska J; Papousek I; Pasekova K; Meissner W; Hordowski J; Cizek A; Literak I
    Appl Environ Microbiol; 2015 Jan; 81(2):648-57. PubMed ID: 25381245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.
    Matsumura Y; Pitout JDD; Peirano G; DeVinney R; Noguchi T; Yamamoto M; Gomi R; Matsuda T; Nakano S; Nagao M; Tanaka M; Ichiyama S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584160
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.
    Merino I; Hernández-García M; Turrientes MC; Pérez-Viso B; López-Fresneña N; Diaz-Agero C; Maechler F; Fankhauser-Rodriguez C; Kola A; Schrenzel J; Harbarth S; Bonten M; Gastmeier P; Canton R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2018 Nov; 73(11):2973-2980. PubMed ID: 30124851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
    Birgy A; Levy C; Nicolas-Chanoine MH; Cointe A; Hobson CA; Magnan M; Bechet S; Bidet P; Cohen R; Bonacorsi S
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of the Colistin Resistance Gene
    Mikhayel M; Leclercq SO; Sarkis DK; Doublet B
    Microbiol Spectr; 2021 Oct; 9(2):e0002521. PubMed ID: 34494875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
    Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
    Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated acquisition and chromosomal integration of
    Komori K; Aoki K; Harada S; Ishii Y; Tateda K
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0081724. PubMed ID: 39133024
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.
    Aslantaş Ö; Yilmaz EŞ
    J Vet Med Sci; 2017 Jun; 79(6):1024-1030. PubMed ID: 28450661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing
    Kawamura K; Hayashi K; Matsuo N; Kitaoka K; Kimura K; Wachino JI; Kondo T; Iinuma Y; Murakami N; Fujimoto S; Arakawa Y
    Microb Drug Resist; 2018 Dec; 24(10):1513-1520. PubMed ID: 29791251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China.
    Liu H; Zhou H; Li Q; Peng Q; Zhao Q; Wang J; Liu X
    BMC Microbiol; 2018 Oct; 18(1):125. PubMed ID: 30286725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal/subclonal changes and accumulation of CTX-M-type β-lactamase genes in fluoroquinolone-resistant Escherichia coli ST131 and ST1193 strains isolated during the past 12 years, Japan.
    Fukushima Y; Sato T; Tsukamoto N; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
    J Glob Antimicrob Resist; 2021 Dec; 27():150-155. PubMed ID: 34509695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras PD; Johnson JR
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115034. PubMed ID: 32331800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.